Sepset Biosciences Inc. is in the final stages of preparation for clinical studies and commercialization of an in vitro diagnostic test that involves a patient gene expression signature that helps assess the development of severe sepsis.
VANCOUVER, BC, April 5, 2024 /PRNewswire/ – Asep Medical Holdings Inc. (“Asep” or the “Company”) (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is very pleased to announce that its joint venture company with leading Chinese biotech company Sansure Biotech Inc. (“Sansure“), Hunan Sanway SepSMART Ltd. (“SepSMART“), which is based in Changsha, China, has obtained its business license and is now […]
VANCOUVER, BC, April 5, 2024 /PRNewswire/ - Asep Medical Holdings Inc. is very pleased to announce that its joint venture company with leading Chinese biotech company Sansure Biotech Inc. ,.